Dr. Michael J. Naslund, MD

Dr. Naslund practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Naslund's NPI, 1750398343, was assigned on August 3, 2006. Dr. Naslund graduated from Johns Hopkins University School of Medicine in 1981. Dr. Naslund holds Maryland license D27182.

Dr. Naslund's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Naslund's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Naslund is also affiliated with University of Maryland Medical Center Midtown Campus. The medical group on file is University of Maryland Surgical Care. Dmand AI also links Dr. Naslund to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Naslund practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Naslund's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Naslund is licensed in Maryland.

CMS data shows 1,498 Medicare services from Dr. Naslund across 17 procedure codes in 2024, for 755 Medicare patients. Medicare paid $116,122 for them.

CMS counts 755 Medicare patients who saw Dr. Naslund in 2024. The largest group is 65 to 74, with 334 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Naslund's median patient age at 67, with 14% women.

In 2024, Dr. Naslund wrote 1,049 Medicare Part D claims for 305 patients. 98% of them were for generic drugs. CMS names the drug for 969 of them, across 11 drugs with 11 or more claims each, at $39,824 in total drug cost. In 2023, CMS named 911 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Naslund for performance year 2024, reported as part of a group. Dr. Naslund accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 30 papers to Dr. Naslund, published from 2011 to 2023. 2016 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Black or African American and Early Detection of Cancer. Dr. Naslund has published most often in Curr Urol. Dr. Naslund's most frequent co-authors are Adrianna Jiaying Lee, MD, Pradip P. Amin, MD and Arif Hussain, MD.

CMS Open Payments shows 124 general payments to Dr. Naslund from 40 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. Augmenix, Inc. paid the most, $3,883.

Dr. Naslund graduated from Johns Hopkins University School of Medicine in 1981.